VITIM & CO AND MORON LTD.
Vitim has established growing pharmacy chain operations in Moscow and the Moscow region under the Stary Lekar brand, and it is the third largest pharmacy chain in Moscow with a market share of some 5 percent in 2007. The Stary Lekar brand has been rated as one of the best-known among Moscow's pharmacy chains. The pharmacy chain is based on a new pharmacy concept with modern sales and management technologies and a combined assortment of both pharmaceuticals and OTC products. Vitim currently oper... ates some 140 pharmacies and employs 1600 persons. Net sales were EUR 76 million in 2007 (EUR 63 million in 2006) with EBIT of an estimated at EUR -3 million in 2007 (EUR 0 million in 2006) reflecting the rapid rate of new pharmacy openings. The operational pharmacies are clearly profitable and well-located. Vitim has invested heavily in expanding the pharmacy chain within the last few years and Oriola-KD is committed to continue the strong growth within the next few years. In 2008 net sales of Vitim are expected to grow strongly while the profitability will still be affected by the continuing establishment of new pharmacies.
VITIM & CO AND MORON LTD.
Industry:
Pharmaceutical
Founded:
1999-01-01
Address:
Moscow, Moscow City, Russian Federation
Country:
Russian Federation
Status:
Active
More informations about "Vitim & Co and Moron Ltd."
Vitim & Co and Moron Ltd. - Crunchbase Company Profile
Vitim & Co and Moron Ltd. is located in Moscow, Moscow City, Russian Federation. Vitim & Co and Moron has established growing pharmacy chain operations in Moscow and the Moscow โฆSee details»
Acquisitions and divestments - Oriola
Aug 31, 2006ย ยท Oriola-KD signed an agreement to acquire a 75 per cent share of the Moscow-based Russian pharmaceutical retail and wholesale companies Vitim & Co and Moron Ltd. โฆSee details»
Vitim & Co and Moron Ltd. acquired by Oriola - Crunchbase
Vitim & Co and Moron Ltd. Vitim & Co and Moron has established growing pharmacy chain operations in Moscow and the Moscow region under the Stary Lekar brand. Acquiring โฆSee details»
Oriola-KD To Enter Growing Russian Pharmaceutical Retail And โฆ
The acquisition of Vitim and Moron is a major strategic step forward for Oriola-KD in investing in Russia's fast-growing pharmaceutical market. Vitim is operating in pharmacy retail in Moscow โฆSee details»
Vitim & Co and Moron Ltd. - Drug pipelines, Patents, Clinical trials ...
Explore Vitim & Co and Moron Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Oriola-KD has made the closing of the Russian acquisition
Jul 10, 2024ย ยท As part of the acquisition a Finnish company under the name Foreti Oy has been founded which fully owns the Moscow-based pharmacy retail company Vitim and the โฆSee details»
Oriola-KD acquire Russian pharma firms - Hospital Pharmacy ...
Mar 31, 2008ย ยท Scandinavian pharmaceutical corporation Oriola-KD has signed an agreement to acquire a 75% share of the Moscow-based pharmaceutical retail and wholesale companies โฆSee details»
Oriola-KD has made the closing of the Russian acquisition
Apr 21, 2008ย ยท As part of the acquisition a Finnish company under the name Foreti Oy has been founded which fully owns the Moscow-based pharmacy retail company Vitim and the โฆSee details»
Oriola Oyj, Founding: 1948, Expansion beyond pharmaceuticals
The company expanded its operations in Russia as well, entering the retail pharmacy market, and acquiring full control of Moron Ltd., as well as another company, Vitim & Co., in 2008. Both โฆSee details»
Oriola - Funding, Financials, Valuation & Investors - Crunchbase
Oriola is a company that helps human beings to live a healthy life by supplying medicines & other wellbeing products through pharmacies.See details»
Oriola-KD to enter Growing Russian Pharmaceutical Retail
Oriola-KD Corporation has signed an agreement to acquire a 75 percent share of the Moscow-based Russian pharmaceutical retail and wholesale companies Vitim & Co and Moron Ltd. โฆSee details»
New General Directors for Oriola-KD's Russian subsidiaries
Apr 3, 2009ย ยท Igor and Oleg Yankov will leave their General Director positions and they will continue as Board members of Vitim and Moron.See details»
Oriola-KD to enter growing Russian pharmaceutical retail and โฆ
Our purpose, โHealth for lifeโ, encompasses the meaning of our daily work.See details»
Oriola-KD to enter growing Russian pharmaceutical retail and โฆ
Mar 17, 2008ย ยท Oriola-KD Corporation has signed an agreement to acquire a 75 percent share of the Moscow-based Russian pharmaceutical retail and wholesale companies Vitim & Co and โฆSee details»
Oriola-KD Corporation's interim report for 1 January - 30
Aug 21, 2008ย ยท Oriola-KD Corporation's interim report for 1 January - 30 June 2008. August 21, 2008 01:30 ET | Source: Oriola-KD Oyj ...See details»
Finnish Oriola-KD Buys Into Russian Market | Reuters
Mar 17, 2008ย ยท Finnish drugs distributor Oriola-KD
Oriola enters Russian pharma market - Pharmaceutical industry โฆ
Mar 24, 2008ย ยท The Finnish Oriola-KD group has agreed to acquire a 75% stake in the Russian pharmaceutical wholesale and retail companies Vitim & Co and Moron Ltd. It will pay between โฆSee details»
Oriola-KD to Enter Growing Russian Pharmaceutical Retail and
Transcription . Oriola-KD to Enter Growing Russian Pharmaceutical Retail andSee details»
Russian Company LLC "VITIM" - ReadyRatios
May 25, 2024ย ยท Organization with TIN 7714330737 (LIMITED LIABILITY COMPANY "VITIM"): all data from the Unified State Register of Legal Entities (USRLE).See details»
Oriola-KD to enter growing Russian pharmaceutical retail and โฆ
Oriola Oyj Company Announcement Oriola-KD to enter growing Russian pharmaceutical retail and wholesale marketsSee details»